Introducing Borsantrazole: A Trifunctional Boron-Based Pyrazole That Extends the Lifespan of Amyotrophic Lateral Sclerosis Mice.
Novel boron compound extends survival in ALS mouse model, offering rare glimmer of hope in this devastating disease.
This study introduces borsantrazole, a trifunctional boron-containing pyrazole compound, demonstrating significant lifespan extension in the SOD1-G93A ALS mouse model through a multi-target mechanism. ALS remains a disease with very limited treatment options (riluzole, edaravone), and the identification of a novel chemical scaffold with survival benefit in a validated ALS model is a high-priority preclinical signal.
What the study was
- Study design
- Preclinical in vivo mouse model
- Population
- ALS (SOD1-G93A) transgenic mice
- Category
- Drug Development
- Maturity
- Exploratory
- Journal
- Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Why it surfaced
ALS is a fatal rare disease with extreme unmet need and no curative therapy. Novel chemical scaffold (boron-based trifunctional pyrazole) extending lifespan in ALS mice published in Advanced Science (high-impact journal). Score capped at 5 (non-human) but NOVEL_TREATMENT flag applied.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.